Stockreport

BRIEF-Biondvax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency [Reuters]

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
PDF BRIEF-Biondvax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency | Reuters Reuters Staff 1 Min Read Dec 27 (Reuters) [Read more]